HER-1 vaccine (Center of Molecular Immunology)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHER-1 vaccine (Center of Molecular Immunology)
Drug Alias NameHER1-ECDHER1-VSSPHER-1-ECD-VSSP
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCenter Of Molecular Immunology
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A